<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39314212</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-889X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in molecular biosciences</Title><ISOAbbreviation>Front Mol Biosci</ISOAbbreviation></Journal><ArticleTitle>Exploring metabolic anomalies in COVID-19 and post-COVID-19: a machine learning approach with explainable artificial intelligence.</ArticleTitle><Pagination><StartPage>1429281</StartPage><MedlinePgn>1429281</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1429281</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmolb.2024.1429281</ELocationID><Abstract><AbstractText>The COVID-19 pandemic, caused by SARS-CoV-2, has led to significant challenges worldwide, including diverse clinical outcomes and prolonged post-recovery symptoms known as Long COVID or Post-COVID-19 syndrome. Emerging evidence suggests a crucial role of metabolic reprogramming in the infection's long-term consequences. This study employs a novel approach utilizing machine learning (ML) and explainable artificial intelligence (XAI) to analyze metabolic alterations in COVID-19 and Post-COVID-19 patients. Samples were taken from a cohort of 142 COVID-19, 48 Post-COVID-19, and 38 control patients, comprising 111 identified metabolites. Traditional analysis methods, like PCA and PLS-DA, were compared with ML techniques, particularly eXtreme Gradient Boosting (XGBoost) enhanced by SHAP (SHapley Additive exPlanations) values for explainability. XGBoost, combined with SHAP, outperformed traditional methods, demonstrating superior predictive performance and providing new insights into the metabolic basis of the disease's progression and aftermath. The analysis revealed metabolomic subgroups within the COVID-19 and Post-COVID-19 conditions, suggesting heterogeneous metabolic responses to the infection and its long-term impacts. Key metabolic signatures in Post-COVID-19 include taurine, glutamine, alpha-Ketoglutaric acid, and LysoPC a C16:0. This study highlights the potential of integrating ML and XAI for a fine-grained description in metabolomics research, offering a more detailed understanding of metabolic anomalies in COVID-19 and Post-COVID-19 conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Oropeza-Valdez, Padron-Manrique, V&#xe1;zquez-Jim&#xe9;nez, Soberon and Resendis-Antonio.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Oropeza-Valdez</LastName><ForeName>Juan Jos&#xe9;</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Human Systems Biology Laboratory. Instituto Nacional de Medicina Gen&#xf3;mica (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Ciencias de la Complejidad, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Padron-Manrique</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Human Systems Biology Laboratory. Instituto Nacional de Medicina Gen&#xf3;mica (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de Doctorado en Ciencias Biom&#xe9;dicas, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Jim&#xe9;nez</LastName><ForeName>Aar&#xf3;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Human Systems Biology Laboratory. Instituto Nacional de Medicina Gen&#xf3;mica (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soberon</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Centro de Ciencias de la Complejidad, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ingenier&#xed;a Celular y Biocat&#xe1;lisis, Instituto de Biotecnolog&#xed;a, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Colonia Chamilpa, Cuernavaca, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resendis-Antonio</LastName><ForeName>Osbaldo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Human Systems Biology Laboratory. Instituto Nacional de Medicina Gen&#xf3;mica (INMEGEN), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Ciencias de la Complejidad, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coordinaci&#xf3;n de la Investigaci&#xf3;n Cient&#xed;fica - Red de Apoyo a la Investigaci&#xf3;n, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Mol Biosci</MedlineTA><NlmUniqueID>101653173</NlmUniqueID><ISSNLinking>2296-889X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">explainable artificial intelligence (XAI)</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">machine learning (ML)</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39314212</ArticleId><ArticleId IdType="pmc">PMC11417410</ArticleId><ArticleId IdType="doi">10.3389/fmolb.2024.1429281</ArticleId><ArticleId IdType="pii">1429281</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdallah A. M., Doudin A., Sulaiman T. O., Jamil O., Arif R., Sada F. A., et al. (2024). Metabolic predictors of COVID-19 mortality and severity: a survival analysis. Front. Immunol. 15, 1353903. 10.3389/fimmu.2024.1353903</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1353903</ArticleId><ArticleId IdType="pmc">PMC11127595</ArticleId><ArticleId IdType="pubmed">38799469</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sulaiman K., Aljuhani O., Badreldin H. A., Korayem G. B., Alenazi A. A., Alharbi A. H., et al. (2023). The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study. BMC Infect. Dis. 23, 75. 10.1186/s12879-023-08010-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08010-8</ArticleId><ArticleId IdType="pmc">PMC9901824</ArticleId><ArticleId IdType="pubmed">36747136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansone L., Rovite V., Br&#x12b;v&#x12b;ba M., Jagare L., Pelcmane L., Borisova D., et al. (2024). Longitudinal NMR-based metabolomics study reveals how hospitalized COVID-19 patients recover: evidence of dyslipidemia and energy metabolism dysregulation. Int. J. Mol. Sci. 25, 1523. 10.3390/ijms25031523</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25031523</ArticleId><ArticleId IdType="pmc">PMC10855192</ArticleId><ArticleId IdType="pubmed">38338803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayd&#x131;n H., Tekin Y. K., Korkmaz &#x130;., Tekin G., Yurtbay S., Kele&#x15f; S., et al. (2022). Glutamine-driven metabolic adaptation to COVID-19 infection. Indian J. Clin. biochem. 38, 83&#x2013;93. 10.1007/s12291-022-01037-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-022-01037-9</ArticleId><ArticleId IdType="pmc">PMC8992789</ArticleId><ArticleId IdType="pubmed">35431470</ArticleId></ArticleIdList></Reference><Reference><Citation>Baliou S., Adamaki M., Ioannou P., Pappa A., Panayiotidis M. I., Spandidos D. A., et al. (2021). Protective role of taurine against oxidative stress (Review). Mol. Med. Rep. 24, 605&#x2013;619. 10.3892/mmr.2021.12242</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12242</ArticleId><ArticleId IdType="pmc">PMC8240184</ArticleId><ArticleId IdType="pubmed">34184084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Anagnostopoulos A., Domenghino A., Aschmann H. E., Frei A., et al. (2023). Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ 381, e074425. 10.1136/bmj-2022-074425</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bifarin O. O. (2023). Interpretable machine learning with tree-based shapley additive explanations: application to metabolomics datasets for binary classification. PLoS One 18, e0284315. 10.1371/journal.pone.0284315</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0284315</ArticleId><ArticleId IdType="pmc">PMC10159207</ArticleId><ArticleId IdType="pubmed">37141218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Forssten M. P., Sarani B., Montgomery S., Mohseni S. (2023). Development and validation of an XGBoost-algorithm-powered survival model for predicting in-hospital mortality based on 545,388 isolated severe traumatic brain injury patients from the TQIP Database. J. Pers. Med. 13, 1401. 10.3390/jpm13091401</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13091401</ArticleId><ArticleId IdType="pmc">PMC10533165</ArticleId><ArticleId IdType="pubmed">37763168</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC (2023). Long COVID or post-COVID conditions. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.
</Citation></Reference><Reference><Citation>Ceballos F. C., Virseda-Berdices A., Resino S., Ryan P., Mart&#xed;nez-Gonz&#xe1;lez O., Per&#xe9;z-Garc&#xed;a F., et al. (2022). Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation. Front. Immunol. 13, 925558. 10.3389/fimmu.2022.925558</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.925558</ArticleId><ArticleId IdType="pmc">PMC9280146</ArticleId><ArticleId IdType="pubmed">35844615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S. B. RECOVER Mechanistic Pathways Task Force (2023a). Viral persistence, reactivation, and mechanisms of long COVID. Elife 12. 10.7554/elife.86015</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Wu M., He Y., Jiang B., He M.-L. (2023b). Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. Signal Transduct. Target. Ther. 8, 237&#x2013;323. 10.1038/s41392-023-01510-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01510-8</ArticleId><ArticleId IdType="pmc">PMC10244875</ArticleId><ArticleId IdType="pubmed">37286535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Guestrin C. (2016). &#x201c;XGBoost,&#x201d; in Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining (New York, NY, USA: ACM; ). 10.1145/2939672.2939785</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2939672.2939785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Gu M., Li T., Sun Y. (2021). Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response. Future Microbiol. 16, 577&#x2013;588. 10.2217/fmb-2021-0047</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2021-0047</ArticleId><ArticleId IdType="pmc">PMC8112156</ArticleId><ArticleId IdType="pubmed">33973485</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmiel F. P., Burns D. K., Azor M., Borca F., Boniface M. J., Zlatev Z. D., et al. (2021). Using explainable machine learning to identify patients at risk of reattendance at discharge from emergency departments. Sci. Rep. 11, 21513. 10.1038/s41598-021-00937-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00937-9</ArticleId><ArticleId IdType="pmc">PMC8563762</ArticleId><ArticleId IdType="pubmed">34728706</ArticleId></ArticleIdList></Reference><Reference><Citation>
Clinical Spectrum. COVID-19 Treatment Guidelines. Available at: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.
</Citation></Reference><Reference><Citation>Cooper A., Doyle O., Bourke A. (2021). &#x201c;Supervised clustering for subgroup discovery: an application to COVID-19 symptomatology,&#x201d; in Communications in computer and information science (Cham: Springer International Publishing; ), 408&#x2013;422.</Citation></Reference><Reference><Citation>Correia B. S. B., Ferreira V. G., Piagge P. M. F. D., Almeida M. B., Assun&#xe7;&#xe3;o N. A., Raimundo J. R. S., et al. (2022). 1H qNMR-based metabolomics discrimination of covid-19 severity. J. Proteome Res. 21, 1640&#x2013;1653. 10.1021/acs.jproteome.1c00977</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00977</ArticleId><ArticleId IdType="pubmed">35674498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruzat V., Macedo Rogero M., Noel Keane K., Curi R., Newsholme P. (2018). Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10, 1564. 10.3390/nu10111564</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111564</ArticleId><ArticleId IdType="pmc">PMC6266414</ArticleId><ArticleId IdType="pubmed">30360490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyprian F. S., Doudin A., Khatib M., Elrayess M., Yassine H., Musa A. (2023). Metabolic profiling of COVID-19 severity and mortality: a targeted metabolomics approach. J. Immunol. 210, 236.19. 10.4049/jimmunol.210.supp.236.19</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.210.supp.236.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehhaghi M., Heydari M., Panahi H. K. S., Lewin S. R., Heng B., Brew B. J., et al. (2024). The roles of the kynurenine pathway in COVID-19 neuropathogenesis. Infection, 1&#x2013;17. 10.1007/s15010-024-02293-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-024-02293-y</ArticleId><ArticleId IdType="pubmed">38802702</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans E. D., Duvallet C., Chu N. D., Oberst M. K., Murphy M. A., Rockafellow I., et al. (2020). Predicting human health from biofluid-based metabolomics using machine learning. Sci. Rep. 10, 17635. 10.1038/s41598-020-74823-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74823-1</ArticleId><ArticleId IdType="pmc">PMC7572502</ArticleId><ArticleId IdType="pubmed">33077825</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanelli G., Lelli V., Rinalducci S., Timperio A. M. (2024). Amino acid metabolism in leukocytes showing in vitro IgG memory from SARS-CoV2-infected patients. Diseases 12, 43. 10.3390/diseases12030043</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases12030043</ArticleId><ArticleId IdType="pmc">PMC10968782</ArticleId><ArticleId IdType="pubmed">38534967</ArticleId></ArticleIdList></Reference><Reference><Citation>
Filho M. (2023). Do decision trees need feature scaling or normalization?
Available at: https://forecastegy.com/posts/do-decision-trees-need-feature-scaling-or-normalization/.
</Citation></Reference><Reference><Citation>Galv&#xe1;n-Tejada C. E., Herrera-Garc&#xed;a C. F., Godina-Gonz&#xe1;lez S., Villagrana-Ba&#xf1;uelos K. E., Amaro J. D. D. L., Herrera-Garc&#xed;a K., et al. (2020). Persistence of COVID-19 symptoms after recovery in Mexican population. Int. J. Environ. Res. Public Health 17, 9367. 10.3390/ijerph17249367</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249367</ArticleId><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Meoni G., Pelagatti L., Celli T., Veneziani F., Petrucci F., et al. (2022). Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients. PLoS Pathog. 18, e1010443. 10.1371/journal.ppat.1010443</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010443</ArticleId><ArticleId IdType="pmc">PMC9022834</ArticleId><ArticleId IdType="pubmed">35446921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Vieri W., Celli T., Pecchioli V., Boccia N., Alonso-V&#xe1;squez T., et al. (2023). COVID-19: a complex disease with a unique metabolic signature. PLoS Pathog. 19, e1011787. 10.1371/journal.ppat.1011787</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011787</ArticleId><ArticleId IdType="pmc">PMC10662774</ArticleId><ArticleId IdType="pubmed">37943960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghojogh B., Ghodsi A., Karray F., Crowley M. (2021). Uniform manifold approximation and projection (UMAP) and its variants: tutorial and survey. 10.48550/ARXIV.2109.02508</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.2109.02508</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X., Du Y., Ma R., Teng N., Ou S., Zhao H., et al. (2023). Construction of the XGBoost model for early lung cancer prediction based on metabolic indices. BMC Med. Inf. Decis. Mak. 23, 107&#x2013;116. 10.1186/s12911-023-02171-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-023-02171-x</ArticleId><ArticleId IdType="pmc">PMC10262551</ArticleId><ArticleId IdType="pubmed">37312179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan C. A., Rajpurkar P., Sowrirajan H., Phillips N. A., Le A. T., Wu M., et al. (2021). Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza. EBioMedicine 71, 103546. 10.1016/j.ebiom.2021.103546</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103546</ArticleId><ArticleId IdType="pmc">PMC8385175</ArticleId><ArticleId IdType="pubmed">34419924</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal P., Ata F., Chaudhry H., Muthanna B., Waqas Younas H., Munamm S. A. U., et al. (2023). Post&#x2010;COVID&#x2010;19&#x2010;associated multiorgan complications or &#x2018;long COVID&#x2019; with literature review and management strategy discussion: a meta&#x2010;analysis. Health Sci. Rep. 6, e1211. 10.1002/hsr2.1211</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1211</ArticleId><ArticleId IdType="pmc">PMC10103688</ArticleId><ArticleId IdType="pubmed">37064319</ArticleId></ArticleIdList></Reference><Reference><Citation>
Is Normalization necessary?. Available at: https://github.com/dmlc/xgboost/issues/357 (Accessed June 17, 2015).</Citation></Reference><Reference><Citation>Jia H., Liu C., Li D., Huang Q., Liu D., Zhang Y., et al. (2022). Metabolomic analyses reveal new stage-specific features of COVID-19. Eur. Respir. J. 59, 2100284. 10.1183/13993003.00284-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00284-2021</ArticleId><ArticleId IdType="pmc">PMC8311281</ArticleId><ArticleId IdType="pubmed">34289974</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodeir M. M., Shabana H. A., Rasheed Z., Alkhamiss A. S., Khodeir M., Alkhowailed M. S., et al. (2021). COVID-19: post-recovery long-term symptoms among patients in Saudi Arabia. PLoS One 16, e0260259. 10.1371/journal.pone.0260259</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260259</ArticleId><ArticleId IdType="pmc">PMC8654233</ArticleId><ArticleId IdType="pubmed">34879074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Miller B. J., Stefanek M. E., Miller A. H. (2015). Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: relevance to cancer-related fatigue. Cancer 121, 2129&#x2013;2136. 10.1002/cncr.29302</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.29302</ArticleId><ArticleId IdType="pubmed">25728366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-H., Kim H.-J., Kim S., Kang J.-S., Koo Y. T., Lee S. H., et al. (2022). A comparative study of antifatigue effects of taurine and vitamin C on chronic fatigue syndrome. Pharmacol. &amp; Pharm. 13, 300&#x2013;312. 10.4236/pp.2022.138023</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/pp.2022.138023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimhofer T., Lodge S., Whiley L., Gray N., Loo R. L., Lawler N. G., et al. (2020). Integrative modeling of quantitative plasma lipoprotein, metabolic, and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2 infection. J. Proteome Res. 19, 4442&#x2013;4454. 10.1021/acs.jproteome.0c00519</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00519</ArticleId><ArticleId IdType="pubmed">32806897</ArticleId></ArticleIdList></Reference><Reference><Citation>Koufaris C., Nicolaidou V. (2021). Glutamine addiction in virus-infected mammalian cells: a target of the innate immune system? Med. Hypotheses 153, 110620. 10.1016/j.mehy.2021.110620</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110620</ArticleId><ArticleId IdType="pubmed">34130112</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler N. G., Gray N., Kimhofer T., Boughton B., Gay M., Yang R., et al. (2021). Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J. Proteome Res. 20, 2796&#x2013;2811. 10.1021/acs.jproteome.1c00052</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00052</ArticleId><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu Y., Xu G., Xie Y., Wang X., Wu J., et al. (2023). Plasma metabolomic characterization of SARS-CoV-2 Omicron infection. Cell Death Dis. 14, 276&#x2013;312. 10.1038/s41419-023-05791-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-023-05791-3</ArticleId><ArticleId IdType="pmc">PMC10113737</ArticleId><ArticleId IdType="pubmed">37076483</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P., Baranovicova E., Rosolanka R., Simekova K., Bobcakova A., Vysehradsky R., et al. (2022). Persistence of metabolomic changes in patients during post-COVID phase: a prospective, observational study. Metabolites 12, 641. 10.3390/metabo12070641</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070641</ArticleId><ArticleId IdType="pmc">PMC9321209</ArticleId><ArticleId IdType="pubmed">35888766</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Mon&#xe1;rrez-Espino J., L&#xf3;pez D. A. G., Zheng J., Borrego J. C., Torres-Calzada C., et al. (2023b). The plasma metabolome of long COVID patients two years after infection. Sci. Rep. 13, 12420&#x2013;12514. 10.1038/s41598-023-39049-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Mon&#xe1;rrez-Espino J., Oostdam A. S. H. v., Delgado J. E. C., Zhang L., Zheng J., et al. (2021). Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci. Rep. 11, 14732. 10.1038/s41598-021-94171-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94171-y</ArticleId><ArticleId IdType="pmc">PMC8290000</ArticleId><ArticleId IdType="pubmed">34282210</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Oropeza-Valdez J. J., Garc&#xed;a Lopez D. A., Borrego J. C., Murgu M., Valdez J., et al. (2023a). Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery. Front. Mol. Biosci. 10, 1100486. 10.3389/fmolb.2023.1100486</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1100486</ArticleId><ArticleId IdType="pmc">PMC10022496</ArticleId><ArticleId IdType="pubmed">36936993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg S., Lee S.-I. (2017). A unified approach to interpreting model predictions. 10.48550/ARXIV.1705.07874</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.1705.07874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg S. M., Erion G., Chen H., DeGrave A., Prutkin J. M., Nair B., et al. (2020). From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56&#x2013;67. 10.1038/s42256-019-0138-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-019-0138-9</ArticleId><ArticleId IdType="pmc">PMC7326367</ArticleId><ArticleId IdType="pubmed">32607472</ArticleId></ArticleIdList></Reference><Reference><Citation>Manchester M., Anisha Anand A. (2017). Metabolomics: strategies to define the role of metabolism in virus infection and pathogenesis. Adv. Virus Res. 98, 57&#x2013;81. 10.1016/bs.aivir.2017.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2017.02.001</ArticleId><ArticleId IdType="pubmed">28433052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangge H., Herrmann M., Meinitzer A., Pailer S., Curcic P., Sloup Z., et al. (2021). Increased kynurenine indicates a fatal course of COVID-19. Antioxidants (Basel) 10, 1960. 10.3390/antiox10121960</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10121960</ArticleId><ArticleId IdType="pmc">PMC8750518</ArticleId><ArticleId IdType="pubmed">34943063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-G&#xf3;mez L. E., Ibarra-Gonz&#xe1;lez I., Fern&#xe1;ndez-Lainez C., Tusie T., Moreno-Mac&#xed;as H., Martinez-Armenta C., et al. (2022). Metabolic reprogramming in SARS-CoV-2 infection impacts the outcome of COVID-19 patients. Front. Immunol. 13, 936106. 10.3389/fimmu.2022.936106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.936106</ArticleId><ArticleId IdType="pmc">PMC9634751</ArticleId><ArticleId IdType="pubmed">36341434</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes L., Healy J., Melville J.UMAP. (2018). Uniform manifold approximation and projection for dimension reduction. 10.48550/ARXIV.1802.03426</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/ARXIV.1802.03426</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A., Bell M. (2022). XGBoost, A novel explainable AI technique, in the prediction of myocardial infarction: a UK biobank cohort study. Clin. Med. Insights Cardiol. 16, 11795468221133611. 10.1177/11795468221133611</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11795468221133611</ArticleId><ArticleId IdType="pmc">PMC9647306</ArticleId><ArticleId IdType="pubmed">36386405</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer C. S. (2022). Innate metabolic responses against viral infections. Nat. Metab. 4, 1245&#x2013;1259. 10.1038/s42255-022-00652-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00652-3</ArticleId><ArticleId IdType="pubmed">36266542</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z., Chong J., Zhou G., de Lima Morais D. A., Chang L., Barrette M., et al. (2021b). MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388&#x2013;W396. 10.1093/nar/gkab382</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab382</ArticleId><ArticleId IdType="pmc">PMC8265181</ArticleId><ArticleId IdType="pubmed">34019663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z., Zhou G., Chong J., Xia J. (2021a). Comprehensive meta-analysis of COVID-19 global metabolomics datasets. Metabolites 11, 44. 10.3390/metabo11010044</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11010044</ArticleId><ArticleId IdType="pmc">PMC7827862</ArticleId><ArticleId IdType="pubmed">33435351</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D. R., Wilson D. B., Howe A., Munier C. M. L., Patel S. K., et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M., Schellhorn H. E. (2023). Metabolomics of infectious diseases in the era of personalized medicine. Front. Mol. Biosci. 10, 1120376. 10.3389/fmolb.2023.1120376</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1120376</ArticleId><ArticleId IdType="pmc">PMC10233009</ArticleId><ArticleId IdType="pubmed">37275959</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes L. F., Murthy S., Garcia-Gallo E., Irvine M., Merson L., Martin-Loeches I., et al. (2022). Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study. ERJ Open Res. 8, 00552-2021. 10.1183/23120541.00552-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00552-2021</ArticleId><ArticleId IdType="pmc">PMC8669808</ArticleId><ArticleId IdType="pubmed">35169585</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I., Wright Muelas M., Taylor J. M., Davison A. S., Xu Y., Grixti J. M., et al. (2021). Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics 18, 6. 10.1007/s11306-021-01859-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01859-3</ArticleId><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Perez D., Guan H., Madhivanan P., Mathee K., Narasimhan G. (2020). So you think you can PLS-DA? BMC Bioinforma. 21, 2&#x2013;10. 10.1186/s12859-019-3310-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-3310-7</ArticleId><ArticleId IdType="pmc">PMC7724830</ArticleId><ArticleId IdType="pubmed">33297937</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez A., Garc&#xed;a-Pardo G., G&#xf3;mez-Bertomeu F., L&#xf3;pez-Dupla M., Foguet-Romero E., Buz&#xf3;n M. J., et al. (2023). Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery. iScience 26, 107948. 10.1016/j.isci.2023.107948</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107948</ArticleId><ArticleId IdType="pmc">PMC10551651</ArticleId><ArticleId IdType="pubmed">37810253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A. M., Wang Z., Ma J. (2020). Glutamine metabolism and its role in immunity, a comprehensive review. Animals 10, 326. 10.3390/ani10020326</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani10020326</ArticleId><ArticleId IdType="pmc">PMC7070879</ArticleId><ArticleId IdType="pubmed">32092847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., et al. (2020). Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59&#x2013;72. 10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiokawa Y., Date Y., Kikuchi J. (2018). Application of kernel principal component analysis and computational machine learning to exploration of metabolites strongly associated with diet. Sci. Rep. 8, 3426. 10.1038/s41598-018-20121-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20121-w</ArticleId><ArticleId IdType="pmc">PMC5821832</ArticleId><ArticleId IdType="pubmed">29467421</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Gollapalli K., Mangiola S., Schranner D., Yusuf M. A., Chamoli M., et al. (2023). Taurine deficiency as a driver of aging. Science 380, eabn9257. 10.1126/science.abn9257</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn9257</ArticleId><ArticleId IdType="pmc">PMC10630957</ArticleId><ArticleId IdType="pubmed">37289866</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J. W., Lam S. M., Fan X., Cao W. J., Wang S. Y., Tian H., et al. (2020). Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 32, 188&#x2013;202. 10.1016/j.cmet.2020.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebani A., Afonso C., Bekri S. (2018). Advances in metabolome information retrieval: turning chemistry into biology. Part II: biological information recovery. J. Inherit. Metab. Dis. 41, 393&#x2013;406. 10.1007/s10545-017-0080-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-017-0080-0</ArticleId><ArticleId IdType="pmc">PMC5959951</ArticleId><ArticleId IdType="pubmed">28842777</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirupathi A., Pinho R. A., Baker J. S., Istv&#xe1;n B., Gu Y. (2020). Taurine reverses oxidative damages and restores the muscle function in overuse of exercised muscle. Front. Physiol. 11, 582449. 10.3389/fphys.2020.582449</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.582449</ArticleId><ArticleId IdType="pmc">PMC7649292</ArticleId><ArticleId IdType="pubmed">33192592</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J. A., Nemkov T., Bertolone L., Francis R. O., et al. (2020). COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, e140327. 10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Vallianou N. G., Karampela I., Christodoulatos G. S., Papavasileiou G., Petropoulou D., et al. (2023). Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int. J. Mol. Sci. 24, 10458. 10.3390/ijms241310458</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241310458</ArticleId><ArticleId IdType="pmc">PMC10341908</ArticleId><ArticleId IdType="pubmed">37445634</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaten L., Postma E. O., van den Herik J. (2009). Dimensionality reduction: a comparative review. Tilburg, Netherland: Tilburg centre for Creative Computing, Tilburg University, 2009&#x2013;2005.</Citation></Reference><Reference><Citation>Wang Z., Ohata Y., Watanabe Y., Yuan Y., Yoshii Y., Kondo Y., et al. (2020). Taurine improves lipid metabolism and increases resistance to oxidative stress. J. Nutr. Sci. Vitaminol. 66, 347&#x2013;356. 10.3177/jnsv.66.347</Citation><ArticleIdList><ArticleId IdType="doi">10.3177/jnsv.66.347</ArticleId><ArticleId IdType="pubmed">32863308</ArticleId></ArticleIdList></Reference><Reference><Citation>What Do I., Lansang N. M., Gopaul U., Ogawa E. F., Heyn P. C., Santos F. H., et al. (2023). Need to know about long-covid-related fatigue, brain fog, and mental health changes? Arch. Phys. Med. Rehabil. 104, 996&#x2013;1002. 10.1016/j.apmr.2022.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2022.11.021</ArticleId><ArticleId IdType="pmc">PMC10028338</ArticleId><ArticleId IdType="pubmed">36948378</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/?mapFilter=deaths.
</Citation></Reference><Reference><Citation>Yi F., Yang H., Chen D., Qin Y., Han H., Cui J., et al. (2023). XGBoost-SHAP-based interpretable diagnostic framework for alzheimer&#x2019;s disease. BMC Med. Inf. Decis. Mak. 23, 137. 10.1186/s12911-023-02238-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-023-02238-9</ArticleId><ArticleId IdType="pmc">PMC10369804</ArticleId><ArticleId IdType="pubmed">37491248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Li H., Li J., Xu B., Xu J. (2022). The mechanism of multiple organ dysfunction syndrome in patients with COVID&#x2010;19. J. Med. Virol. 94, 1886&#x2013;1892. 10.1002/jmv.27627</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27627</ArticleId><ArticleId IdType="pmc">PMC9015222</ArticleId><ArticleId IdType="pubmed">35088424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>